Search results
Ipsen is a mid-sized global biopharmaceutical company that develops transformative medicines in oncology, rare disease and neuroscience. Learn about its strategy, culture, pipeline, partnerships, financial results and sustainability goals.
- Français FR
Ipsen s’investit dans la sauvegarde et la préservation de...
- Investors
Discover Ipsen in two pages; our products and key figures,...
- Financial Results
Building on solid FY 2023 results, Ipsen anticipates four...
- Corporate News
Ipsen completes acquisition of Albireo, expanding the scope...
- Financial Calendar
Find information on Ipsen’s financial calendar, including...
- Regulated Information
IPSEN – Buy-back programme – Art 5 of MAR – Week 23 – 2024...
- Patients
Ipsen unites all our employees behind our global commitment...
- Ukraine
Ipsen пропонує захоплюючі можливості, які кинуть виклик...
- Français FR
Ipsen is a mid-size pharmaceutical company that develops and markets products in oncology, rare disease and neuroscience. Learn about its history, strategy, ESG commitment, global presence and Fondation Ipsen.
Ipsen is a French biopharmaceutical company headquartered in Paris, France, with a focus on drug development and commercialization in three therapeutic areas: oncology, rare diseases and neuroscience. Ipsen is one of the world's top 15 biopharmaceutical companies in terms of oncology sales.
Ipsen designs and manufactures industrial vacuum furnaces, atmosphere furnaces, and controls for thermal processing markets.
Ipsen is a public company that develops and markets medicines in oncology, rare disease and neuroscience. It has offices and employees in more than 40 countries and a pipeline fueled by external innovation.
Explore Ipsen careers in a variety of fields. Search Ipsen jobs according to your unique skills, and make a real impact on patients’ lives.
Ipsen is a mid-size biopharmaceutical company with over 5,000 employees and products registered in 88 countries. It aims to innovate for patients with high unmet medical need and has a history of nearly 100 years in the industry.